Ardent Health ARDT Ratios (2023-2026)

NYSE ARDT
$10.76 -0.15 (-1.38%)
As of: Sep 3, 2026 · 3:59 PM EDT
Reported Financials

Ardent Health Quarterly Ratios

Periods 13 quarters
Latest Jun 2026

Ardent Health reported a gross margin of 82.76% and a net margin of 2.14% for the quarter ended Jun 2026. These financial ratios cover 13 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin 81.53%81.89%81.45%82.09%82.37%82.63%83.56%82.71%83.55%82.50%82.71%83.24%82.76%
EBT Margin 4.95%3.34%0.66%3.93%5.59%3.94%10.41%4.96%7.41%-0.14%5.75%4.66%2.66%
EBIT Margin -13.51%-14.78%-17.89%-13.98%-12.05%-13.44%-6.03%-12.33%-9.03%-17.64%-11.54%-12.11%-14.57%
EBITDA Margin -13.51%-14.78%-17.89%-13.98%-12.05%-13.44%-6.03%-12.33%-9.03%-17.64%-11.54%-12.11%-14.57%
Operating Margin -13.51%-14.78%-17.89%-13.98%-12.05%-13.44%-6.03%-12.33%-9.03%-17.64%-11.54%-12.11%-14.57%
Net Margin 4.07%2.81%0.80%3.19%4.55%3.17%8.77%3.94%5.82%0.08%4.63%3.65%2.14%
FCF Margin 4.62%0.75%-2.68%5.54%3.19%2.38%-3.19%4.33%6.06%8.69%-5.51%9.74%
Efficiency
Inventory AverageInventory Avg. 106.62M111.66M117.72M119.38M120.00M120.09M119.22M117.93M
Assets AverageAssets Avg. 4,704.35M4,878.06M4,933.68M4,969.26M5,090.81M5,222.29M5,271.52M5,266.45M
Invested CapitalInvested Cap. 18.61M10.72M12.17M9.23M17.76M19.33M19.34M23.44M37.63M28.57M
Asset Utilization RatioAsset Util. 1.211.221.221.251.241.211.221.22
Leverage & Solvency
Interest Coverage RatioInterest Cover -9.90-10.69-13.05-10.45-9.76-13.32-7.16-13.03-10.09-19.99-14.95-15.88-18.81
Debt Ratio 0.250.240.230.220.230.230.220.210.210.21
Times Interest Earned -9.90-10.69-13.05-10.45-9.76-13.32-7.16-13.03-10.09-19.99-14.95-15.88-18.81
Dividends & Payouts
FCF Payout RatioFCF Cover 0.301.31-0.370.210.460.51-0.400.280.240.19-0.240.14
Dividend YieldDiv. Yield 0.82%0.81%0.98%1.04%1.20%2.05%1.74%1.63%
Payout Ratio 0.491.220.310.260.470.140.330.2118.920.350.360.66
Valuation
Price to EarningsP/E 57.0717.3033.3520.430.00M16.9920.9540.25
Price to SalesP/S 1.811.521.311.191.200.790.760.86
Price to BookP/B 1.891.601.261.191.160.750.710.80
Enterprise Value 2,438.90M1,882.51M1,471.53M1,412.35M1,682.68M950.21M611.77M1,067.44M
EV to EBIT -12.52-19.44-7.97-9.50-6.05-5.13-3.15-4.52
EV to EBITDA -12.52-19.44-7.97-9.50-6.05-5.13-3.15-4.52
Market Capitalization 2,623.43M2,438.13M1,966.77M1,954.73M1,897.00M1,261.49M1,225.23M1,396.40M
Price to FCFP/FCF 56.7463.67-41.2427.4219.859.05-13.878.83
EV to FCF 52.7549.16-30.8519.8117.616.81-6.936.75
EV to CFO 27.1915.74-59.3712.0210.904.25-10.165.43
Return Ratios
Return on Sales [ROS]ROS 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed [ROCE]ROCE -21.33%-17.04%-15.93%-15.29%-17.08%-19.08%-18.65%-20.83%
Return on Invested Capital [ROIC]ROIC -0.29%-0.19%-0.15%-0.13%-0.09%-0.09%-0.09%-0.07%-0.07%
Return on Assets [ROA]ROA 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%